Hinweis-Modus ist eingeschaltet Ausschalten

159316 - E Fund Hang Seng Hong Kong Stock Connect Innovative Drugs ETF (CNY) (CNE100006VJ9)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
CNE100006VJ9
159316 ISIN
Exchange Traded Funds (ETF)
Fondstyp
E Fund Management
Anbieter
-
NAV pro Aktie
18/03/2025
Startdatum
1 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEOXXX
CFI
159316
Ticker
Formed
Status
Equity
Investitionsobjekt
Broad Market
Sektor
Hong Kong
Geographie
CSI Hong Kong Stock Connect Innovative Drug Index
Benchmark
0.6 %
Gesamtkostenquote
Physical
Replikationsmethode
Nein
UCITS
Passive (Index)
Management Style

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (159316)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

Fund profile

The E Fund Hang Seng Hong Kong Stock Connect Innovative Drugs ETF seeks to replicate as closely as possible the price and yield performance of the CSI Hong Kong Stock Connect Innovative Drug Index and invests in a portfolio comprised primarily of Hong Kong companies

159316 profile

The E Fund Hang Seng Hong Kong Stock Connect Innovative Drugs ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Broad Market sector located in Hong Kong. The E Fund Management fund’s base currency is CNY and the share class was registered 18.03.2025 with unique ISIN - CNE100006VJ9. Main exchange is Shenzhen SE and ticker symbol is 159316. The total expense ratio is 0.6%. The E Fund Hang Seng Hong Kong Stock Connect Innovative Drugs ETF (CNY) pays dividends 1 time(s) per year.

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.